Clinical Neuropsychology: Open Access
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 141
Clinical Neuropsychology: Open Access received 141 citations as per Google Scholar report
Indexed In
- Google Scholar
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
Useful Links
Recommended Journals
Related Subjects
Share This Page
Clinical Neuropsychology: Open Access : Citations & Metrics Report
Articles published in Clinical Neuropsychology: Open Access have been cited by esteemed scholars and scientists all around the world.
Following are the list of articles that have cited the articles published in Clinical Neuropsychology: Open Access.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
46 | 32 | 15 | 0 | 0 | 0 | 2 | 20 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 31 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
4 | 15 | 34 | 18 | 17 | 10 | 11 | 15 |
| Journal total citations count | 141 |
| Journal impact factor | |
| Journal 5 years impact factor | |
| Journal cite score | |
| Journal h-index since 2019 |
 |
Sultana S. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. |
| View at Publisher | View at Google Scholar | |
|
Cacabelos R. Metabolomics: Open Access. |
| View at Publisher | View at Google Scholar | |
|
Venkateswarlu N. Research and Reviews: Journal of Pharmacology and Toxicological Studies. |
| View at Publisher | View at Google Scholar | |
|
Cacabelos R, Torrellas C, Teijido O, Carril JC. Pharmacogenetic considerations in the treatment of Alzheimer's disease. Pharmacogenomics. 2016 Jun;17(9):1041-74. |
| View at Publisher | View at Google Scholar | |
|
Cacabelos R. Parkinson’s disease: Old concepts and new challenges. Scientific Pages Alzheimers Dis Dement. 2016;1(001). |
| View at Publisher | View at Google Scholar | |
|
Venkateswarlu N. Research and Reviews: Journal of Pharmacology and Toxicological Studies. |
| View at Publisher | View at Google Scholar | |
|
Venkateswarlu N. Research and Reviews: Journal of Pharmacology and Toxicological Studies. |
| View at Publisher | View at Google Scholar | |
|
Cashin A, Theophilos T, Green R. The internationally present perpetual policy themes inhibiting development of the nurse practitioner role in the primary care context: An Australian–USA comparison. Collegian. 2016 May 26. |
| View at Publisher | View at Google Scholar | |
|
Venkateswarlu N. Research and Reviews: Journal of Pharmacology and Toxicological Studies. |
| View at Publisher | View at Google Scholar | |
|
Venkateswarlu N. Research and Reviews: Journal of Pharmacology and Toxicological Studies. |
| View at Publisher | View at Google Scholar | |
|
Sultana S. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. |
| View at Publisher | View at Google Scholar | |
|
Venkateswarlu N. Research and Reviews: Journal of Pharmacology and Toxicological Studies. |
| View at Publisher | View at Google Scholar | |
|
Roldán CO, Álvarez ET, Castillo MP, Sánchez ÁF. INYECTABLES ANTIPSICÓTICOS DE LARGA DURACIÓN: Cuál y Cuándo. 3Ciencias; 2016 Jul 19. |
| View at Publisher | View at Google Scholar | |
